April 6, 2022Open Access

Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study

KCKo ChibaNagasaki University NONarihiro OkazakiYukioka Hospital AKAyako KurogiNagasaki University Hospital

Key Points

Key points are not available for this paper at this time.

Abstract

D-PTH and W-PTH comparably increased Ct.Th, the primary endpoint. D-PTH had a strong effect on trabecular bone. Although D-PTH decreased Ct.vTMD, it increased Ct.Th and total bone strength. W-PTH had a moderate effect on trabecular bone, maintained Ct.vTMD, and increased Ct.Th and total bone strength to the same extent as D-PTH.

KI fragen

Bookmark

View Full Paper

Cite This Study

Chiba et al. (Wed,) studied this question.

synapsesocial.com/papers/69db25f9387cf706986883ec https://doi.org/https://doi.org/10.1016/j.bone.2022.116416

KI fragen

Bookmark

View Full Paper